US Federal 2023-2024 Regular Session

US Federal House Bill HB4091

Introduced
6/14/23  
Refer
6/14/23  

Caption

To amend the SUPPORT for Patients and Communities Act to expand required reports on T-MSIS substance use disorder data to include mental health condition data.

Impact

The bill, if enacted, would require updates to the existing reporting system under the SUPPORT Act, thereby adding mental health conditions to the datasets collected by T-MSIS (Transformed Medicaid Statistical Information System). This shift is expected to lead to better-informed public policies and healthcare strategies that address the needs of individuals dealing with both mental health issues and substance use disorders. By expanding the scope of data collected, lawmakers would have access to clearer information to guide funding and resource allocation, ultimately leading to improved treatment outcomes for affected individuals.

Summary

House Bill 4091 aims to amend the SUPPORT for Patients and Communities Act by expanding the requirement for reporting substance use disorder data to include data on mental health conditions. This bill reflects a growing recognition of the intertwined nature of mental health and substance use issues, advocating for a more comprehensive approach to health data that adequately represents both domains. Its introduction into Congress marks a significant step towards addressing mental health alongside substance-related challenges, aiming for a more inclusive healthcare framework.

Contention

There may be varied opinions regarding the implementation of HB4091, particularly around the challenges of effectively integrating substance use disorder data with mental health information. Stakeholders might raise concerns about the adequacy of current systems to handle the additional data without compromising the quality and specificity needed for effective treatment recommendations. Additionally, discussions may arise on funding to support improved reporting infrastructure and training for healthcare providers to better address dual diagnoses.

Companion Bills

US HB4531

Related Support for Patients and Communities Reauthorization Act

Previously Filed As

US HCR76

Requesting The Department Of Health To Convene A Complex Needs Patient Working Group To Address The Needs, Services, And Funding For Complex Needs Patients Who Have Multiple Significant But Not Severe Diagnoses Of Chronic Conditions, Including Substance Use Disorders, Mental Health Disorders, Or Chronic Physical Illness Conditions.

US HR70

Requesting The Department Of Health To Convene A Complex Needs Patient Working Group To Address The Needs, Services, And Funding For Complex Needs Patients Who Have Multiple Significant But Not Severe Diagnoses Of Chronic Conditions, Including Substance Use Disorders, Mental Health Disorders, Or Chronic Physical Illness Conditions.

US S2560

Permits licensed providers to accompany emergency medical services and treat patients within the community for mental health disorders, including substance use disorders.

US H8134

Permits licensed providers to accompany emergency medical services and treat patients within the community for mental health disorders, including substance use disorders.

US H1439

Mental Health and Substance Use Disorders

US S1620

Mental Health and Substance Use Disorders

US HB1439

Mental Health and Substance Use Disorders :

US HB279

AN ACT relating to coverage for mental health or substance use disorders.

US HB1142

Relating to coverage for mental health conditions and substance use disorders under certain governmental health benefit plans.

US SB636

Relating to coverage for mental health conditions and substance use disorders under certain governmental health benefit plans.

Similar Bills

CA AB1612

Disposition of controlled substances.

MA H2227

Replacing archaic and stigmatizing language for substance use

US HB830

SAFE Act Save Americans from the Fentanyl Emergency Act

MI HB4948

Controlled substances: other; sentencing guidelines for retail sale of products containing ephedrine or pseudoephedrine; modify. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: HB 4947'25

NJ S829

"CJ's Law"; Criminalizes manufacture, sale, and possession of substances containing kratom.

NJ A1617

"CJ's Law"; Criminalizes manufacture, sale, and possession of substances containing kratom.

NJ A1203

"CJ's Law"; Criminalizes manufacture and distribution of substances containing kratom under certain circumstances.

NJ S2271

"CJ's Law"; Criminalizes manufacture and distribution of substances containing kratom under certain circumstances.